Clarapath was founded in 2014 and is currently located at the NY Genome Center in NYC and in Westchester, NY. The company has two business arms: (1) A Clinical Research Organization (CRO) that serves clinical, and research organizations by processing tissue and performing whole slide imaging and automated image processing; and (2) a medical device development group that works on the creation of a device that will automate the sectioning process for anatomical pathology laboratories—both preclinical and clinical laboratories. Clarapath has two locations: the CRO is located in the New York Genome Center, and the device development and Corporate HQ is located in Hawthorne, NY. Our device development team has expertise in medical device development in the automation field, systems design, image processing, software, materials and electronics. The CRO team has expertise in histology laboratory workflow and process.
In order to meet the challenges in today’s histopathology labs, Clarapath has developed an automated, serial tissue sectioning and transfer robotics platform called SectionStar™. This technology significantly improves the efficiency of serial sectioning by automating the transfer of sliced tissues to glass slides via adhesive tape. SectionStar™ will improve overall sample preparation capacity while maximizing sample quality and consistency with minimal oversight.
*Higher Quality Slides*
*Faster Slide Production*
*Large-Scale Image Storage*
Clarapath Inc. has not received any reviews.
Clarapath Inc. has not received any endorsements.